Table 1. Clinical characteristics of patients with dilated cardiomyopathy.
| RNA-seq analysis | Protein analysis RT-qPCR analysis | |
|---|---|---|
| DCM (n = 13) | DCM (n = 20) | |
| Age (years) | 51 ± 11 | 48 ± 13 |
| Gender male (%) | 92 | 82 |
| NYHA class | 3.4 ± 0.4 | 3.3 ± 0.3 |
| Prior smoking (%) | 50 | 56 |
| BMI (kg/m2) | 27 ± 5 | 28 ± 6 |
| Total cholesterol (mg/dL) | 147 ± 37 | 139 ± 44 |
| Prior hypertension (%) | 17 | 21 |
| Prior diabetes mellitus (%) | 17 | 18 |
| Hemoglobin (mg/mL) | 13 ± 3 | 13 ± 3 |
| Hematocrit (%) | 39 ± 8 | 39 ± 7 |
| Duration of disease (months) | 75 ± 68 | 68 ± 63 |
| Echo-Doppler study | ||
| EF (%) | 20 ± 7 | 22 ± 9 |
| FS (%) | 11 ± 4 | 12 ± 5 |
| LVESD (mm) | 71 ± 12 | 67 ± 12 |
| LVEDD (mm) | 80 ± 11 | 76 ± 11 |
| LVMI (g/m2) | 241 ± 77 | 230 ± 75 |
Data are showed as the mean value ± SD. DCM, dilated cardiomyopathy; NYHA, New York Heart Association; BMI, body mass index; EF, ejection fraction; FS, fractional shortening; LVESD, left ventricular end-systolic diameter; LVEDD, left ventricular end-diastolic diameter; LVMI, left ventricular mass index.